Authors


Jingjing Qian, PhD

Latest:

Uptake of Rituximab Biosimilars in Medicare and Medicaid in 2019-2022

Significant uptake of rituximab biosimilars in Medicare and Medicaid occurred within the first 4 years of marketing in the US.


Rachel Bacon, PharmD, MPH

Latest:

Cost-Benefit Analysis of Sacubitril/Valsartan in a Medicaid Population

The cost avoidance of heart failure–related hospitalizations and emergency department visits may outweigh the additional drug cost in Medicaid members adherent to sacubitril/valsartan.


Daniel Dowd, PharmD

Latest:

Predicting Drug-Drug and Drug-Gene Interactions in a Community Pharmacy Population

The probability of drug interactions increases when genetic polymorphisms are considered, indicating that pharmacogenetic assessment may be useful in predicting the presence and severity of interactions.


Mark W. Vander Weg, PhD

Latest:

Effect of a Patient Activation Intervention on Hypertension Medication Optimization: Results From a Randomized Clinical Trial

In patients with hypertension, a patient activation intervention increased rates of switching to a thiazide, suggesting that such interventions may address medication optimization challenges.


Connor Iapoce

Latest:

Lorundrostat Significantly Lowers Blood Pressure in Key Hypertension Trials

New topline data from the Launch-HTN (NCT06153693) and Advance-HTN (NCT06153693) clinical trials show these investigations met their primary end points os statistically significant reductions in systolic blood pressure.


Torie Nugent-Peterson

Latest:

How Employers Can Fight the Price Crisis

This commentary, part of the Price Crisis campaign, focuses on the role of employers and business coalitions in advocating for policy change.


Julia D. Lucaci, PharmD, MS

Latest:

Blister Packs May Help Solve Medication Adherence Challenges and Lower Health Care Costs

Julia Lucaci, PharmD, MS, of Becton, Dickinson and Company, discusses the benefits of blister packaging for chronic medications, advocating for payer incentives to boost medication adherence and improve health outcomes.


Peter Smittenaar, PhD

Latest:

Better Data Is Needed to Tackle Health Equity

The US federal government is finally updating its standards for reporting data on race and ethnicity – and it’s an urgently needed chance to enable a national overview of crucial data on health inequities


Fei Deng, MM

Latest:

How Do Primary Hospitals Enact Early Response to the Relaxation of COVID-19 Prevention and Control Measures? The Experience From Chengdu, China

This article examines how primary hospitals in Chengdu, China, responded to the relaxation of COVID-19 prevention and control measures in December 2022.


Lisa S. Kemp, PhD

Latest:

Association of Co-pay Elimination With Medication Adherence and Total Cost

This study evaluated cost and utilization attributed to members enrolled in a health care program with no pharmacy co-pay. Health care savings were identified in addition to medication adherence improvements.


Patricia Ares-Romero, MD, FASAM

Latest:

Optimizing the Management of TRD

Drs Steven Levine, Patricia Ares-Romero, Samuel Nordberg, Martin Rosenzweig, and Carrie Jardine share insight on the future treatment landscape for TRD.


Dr Marina Kremyanskaya | Image Credit: Mount Sinai
Marina Kremyanskaya, MD, PhD

Latest:

Global Hematology Experts Reflect on Key Takeaways From the EHA 2025 Congress

At the 30th European Hematology Association (EHA) Congress, hematology experts highlight breakthroughs in treatment, the importance of patient voices, and challenges in making innovations accessible worldwide.


Judith L. Strymish, MD

Latest:

Understanding Suboptimal e-Consult Requests: Lessons From the VA

US Department of Veterans Affairs (VA) clinicians’ perspectives on what constitutes a good e-consult and why suboptimal e-consult requests occur contain broadly applicable lessons for other health systems.


Anitha Shrikhande, MD, MPH

Latest:

Patient Education, Provider Education, and Overall Final Thoughts

In this discussion, panelists offer their final thoughts.


Raelle Wilson, MA

Latest:

Breaking Barriers: Partnerships to Improve Diabetic Eye Health in Alabama

This article reviews barriers to diabetic eye health across Alabama and highlights a partnership with Genentech and the American Diabetes Association to address this issue.


Guillaume Germain, MSc

Latest:

Real-World Users of Triple Therapy for Asthma in the US

This retrospective cohort study evaluated baseline demographics, clinical characteristics, and treatment patterns of US patients with asthma who newly initiated single- or multiple-inhaler triple therapy.


William S. Pearson, PhD, MHA

Latest:

Addressing STIs Through Managed Care: Opportunities in Medicaid and Beyond

Medicaid and other managed care organizations could take several key steps to respond to the sexually transmitted infection (STI) epidemic in the US, including congenital syphilis.


Vivian Shi, MD, FAAD

Latest:

Optimizing Multidisciplinary Care of Patients with Hidradenitis Suppurativa

Vivian Shi, MD, FAAD, offers clinical insights on best practices for optimizing multidisciplinary care of patients with hidradenitis suppurativa.


Su-Jau Yang, PhD

Latest:

Real-World Value of Direct-Acting Antivirals for Hepatitis C at Kaiser Permanente Southern California

This analysis demonstrates value and innovation of direct-acting antivirals for the treatment of chronic hepatitis C in the US Kaiser Permanente health system.


Hadii M. Mamudu, PhD, MPA

Latest:

COVID-19 Vaccine Hesitancy and Health Literacy in US Southern States

COVID-19 vaccine hesitancy is not associated with health literacy. Personal perception of threat was associated with reduced vaccine hesitancy.


Kristine Adams, MSN, CNP

Latest:

Food Insecurity, Neighborhood, and Health Care Utilization in Health System Adults

This retrospective study examined food insecurity and neighborhood disadvantage in health system patients as predictors of acute health care utilization.


Debra Patt, MD, PhD, MBA, MPH

Latest:

The “Secret Sauce” in Oncology: The Partnership Between Clinicians and AI

“To error is human, and also to error is in machine learning,” said Debra Patt, MD, PhD, MBA, MPH.


Garen A. Collett, MD

Latest:

Standardized Total Knee Arthroplasty Pathway Improves Outcomes in Minority Patients

In a minority-predominant patient population, a standardized pathway for total knee arthroplasty was associated with improved outcomes with no change in postoperative complication rates.


John Parkinson

Latest:

Live Biotherapeutic Product Remains Effective Against Recurrent CDI After Antibiotic Use

A study showed the Clostridioides difficile infection (CDI) treatment remained effective after subsequent systemic antibiotic exposure.


Anna Bergdall, MPH

Latest:

Care Coordination in Primary Care: Mapping the Territory

A survey completed by 100% of leaders of diverse care systems in Minnesota participating in an observational study showed little difference in approach to care coordination.


Ann C. Mertens, PhD

Latest:

Racial and Ethnic Disparities in Telemental Health Use Among Publicly Insured Children

Among publicly insured children with mental health–related encounters, racial and ethnic disparities in telemental health use widened following the onset of the COVID-19 pandemic.


Arthur L. Jenkins III, MD, FACS

Latest:

Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care

On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.


Mary Schroth, MD, FAAP, FCCP

Latest:

Unmet Needs and the Future of Treatment in SMA

Experts in SMA provide closing thoughts on unmet needs in SMA including the importance of research into treatment combinations and sequencing as well as multidisciplinary care and healthcare equity.


Maria Durham, MBA, MS

Latest:

Actions to Improve Quality: Results From a National Hospital Survey

Hospitals reported widespread adoption of quality improvement (QI) changes to improve on CMS quality measures, and QI adoption was associated with improved performance on quality measures.


Lori Leslie, MD

Latest:

Reflections on 2024’s Progress in R/R CLL

Panelists discuss how the relapsed/refractory chronic lymphocytic leukemia treatment landscape evolved significantly in 2024 with expanded Bruton tyrosine kinase inhibitor options, growing real-world evidence for newer agents, and emerging combination strategies, while expressing optimism for future advances in personalized therapy approaches and novel drug development.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo